Aktis Oncology, Inc.
USD31.94
+1.83 (+6.07%)
CEO
Matthew Roden
IPO Date
2026-01-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$29.63
Prev. Close
$30.11
Day Low
$29.49
Day High
$32.10
52W Low
$14.72
52W High
$33.53
Market Cap
$1.71B
Volume
0.10M
| 0 |
| $0.00 |
| 13 Aug 2024 | Kahn Matthew | director: | Disposed | 0 | $0.00 |
| 31 Jan 2024 | Boller Kenneth | CFO | P-Purchase | Acquired | 60,000 | $0.50 |
| 31 Jan 2024 | Geiss Arthur | director | P-Purchase | Acquired | 50,000 | $0.50 |
| 31 Jan 2024 | Aichele David | EVP of Business Development | P-Purchase | Acquired | 80,000 | $0.50 |
| 31 Jan 2024 | Shealy Jeffrey B. | director, officer: Chief Executive Officer | P-Purchase | Acquired | 1,310,000 | $0.50 |
| 20 Dec 2023 | Boller Kenneth | CFO | S-Sale | Disposed | 1,200 | $0.72 |
| 20 Dec 2023 | Aichele David | EVP of Business Development | S-Sale | Disposed | 1,500 | $0.72 |
| 22 Nov 2023 | Boller Kenneth | CFO | S-Sale | Disposed | 1,700 | $0.59 |